On the public citation graph

Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells

https://doi.org/10.1016/j.nano.2015.07.009
0 signed · 107 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hed.21315openalex-snapshot
Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase
inferredcites →https://doi.org/10.1002/stem.424openalex-snapshot
Permanently Blocked Stem Cells Derived From Breast Cancer Cell Lines
inferredcites →https://doi.org/10.1007/s12032-011-9933-9openalex-snapshot
Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma
inferredcites →https://doi.org/10.1016/j.abb.2014.06.022openalex-snapshot
CD24 regulates stemness and the epithelial to mesenchymal transition through modulation of Notch1 mRNA stability by p38MAPK
inferredcites →https://doi.org/10.1016/j.addr.2004.01.011openalex-snapshot
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid–PEG conjugates
inferredcites →https://doi.org/10.1016/j.cell.2011.07.026openalex-snapshot
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
inferredcites →https://doi.org/10.1016/j.cell.2013.06.005openalex-snapshot
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
inferredcites →https://doi.org/10.1038/nature14034openalex-snapshot
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
inferredcites →https://doi.org/10.1038/nbt0697-542openalex-snapshot
αv Integrins as receptors for tumor targeting by circulating ligands
inferredcites →https://doi.org/10.1038/nnano.2007.387openalex-snapshot
Nanocarriers as an emerging platform for cancer therapy
inferredcites →https://doi.org/10.1038/nrc1590openalex-snapshot
Tumour stem cells and drug resistance
inferredcites →https://doi.org/10.1038/nrc903openalex-snapshot
Ligand-targeted therapeutics in anticancer therapy
inferredcites →https://doi.org/10.1038/nrd2614openalex-snapshot
Nanoparticle therapeutics: an emerging treatment modality for cancer
inferredcites →https://doi.org/10.1038/nrm2060openalex-snapshot
Powering membrane traffic in endocytosis and recycling
inferredcites →https://doi.org/10.1038/onc.2011.421openalex-snapshot
Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential
inferredcites →https://doi.org/10.1074/jbc.270.29.17521openalex-snapshot
The Transcriptional Regulation of Human Aldehyde Dehydrogenase I Gene
inferredcites →https://doi.org/10.1158/0008-5472.can-08-4418openalex-snapshot
Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
inferredcites →https://doi.org/10.1158/1055-9965.epi-09-0865openalex-snapshot
Aldehyde Dehydrogenase 1 A1–Positive Cell Population Is Enriched in Tumor-Initiating Cells and Associated with Progression of Bladder Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-1630openalex-snapshot
Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-0370openalex-snapshot
Notch Pathway Activity Identifies Cells with Cancer Stem Cell–like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
inferredcites →https://doi.org/10.1158/1541-7786.mcr-08-0035openalex-snapshot
Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
inferredcites →https://doi.org/10.1186/1476-4598-13-237openalex-snapshot
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations
inferredcites →https://doi.org/10.1186/bcr2479openalex-snapshot
Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment
inferredcites →https://doi.org/10.1517/17425247.3.3.311openalex-snapshot
Nanoparticle–aptamer bioconjugates for cancer targeting
inferredcites →https://doi.org/10.2217/nnm.12.22openalex-snapshot
Cancer Stem Cells and Drug Resistance: The Potential of Nanomedicine

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4606632openalex-extracted
9,10-Secocycloartane (=9,19-Cyclo-9,10-Secolanostane) Triterpenoidal Saponins Astramembraosides A-L From Astragalus Membranaceus (Fish.) Bge
inferred← citeshttps://doi.org/10.1002/adhm.202101544openalex-snapshot
In Vivo Antitumor and Antimetastatic Efficacy of a Polyacetal‐Based Paclitaxel Conjugate for Prostate Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adma.201902604openalex-snapshot
Ligand‐Installed Nanocarriers toward Precision Therapy
inferred← citeshttps://doi.org/10.1002/advs.201900849openalex-snapshot
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
inferred← citeshttps://doi.org/10.1002/bit.28205openalex-snapshot
Ligand conjugated lipid‐based nanocarriers for cancer theranostics
inferred← citeshttps://doi.org/10.1002/ijc.34447openalex-snapshot
Extracellular vesicles secreted by triple‐negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs
inferred← citeshttps://doi.org/10.1002/smll.202301385openalex-snapshot
Impact of Nanomedicine in Women's Metastatic Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-64668-4_14openalex-snapshot
Recent Update on Nanomedicine-Based Drug Targeting on Colon Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-45594-5_3openalex-snapshot
The Role of Cancer Stem Cells in Tumour Radioresponse
inferred← citeshttps://doi.org/10.1007/978-981-15-5120-8_17openalex-snapshot
Targeting Cancer Stem Cells by Nanoenabled Drug Delivery
inferred← citeshttps://doi.org/10.1007/978-981-16-1638-9_9openalex-snapshot
Nanoparticles and Stem Cells
inferred← citeshttps://doi.org/10.1007/978-981-19-5558-7_9openalex-snapshot
Nanomedicine-Based Combinational Therapy for Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-981-32-9898-9_4openalex-snapshot
Nanomedicine in Cancer Stem Cell Therapy
inferred← citeshttps://doi.org/10.1007/s12032-024-02347-zopenalex-snapshot
Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
inferred← citeshttps://doi.org/10.1016/b978-0-12-809717-5.00001-4openalex-snapshot
Nanotechnology for the Development of Nanomedicine
inferred← citeshttps://doi.org/10.1016/b978-0-323-46144-3.00030-1openalex-snapshot
Nanostructures for cancer therapy: from targeting to selective toxicology
inferred← citeshttps://doi.org/10.1016/b978-0-323-50878-0.00001-xopenalex-snapshot
From the “Magic Bullet” to Advanced Nanomaterials for Active Targeting in Diagnostics and Therapeutics
inferred← citeshttps://doi.org/10.1016/b978-0-323-91763-6.00014-xopenalex-snapshot
Targeted breast cancer treatment: progress and challenges
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2017.07.007openalex-snapshot
Cancer Stem Cells and Metastasis
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114463openalex-snapshot
The in vivo fate of polymeric micelles
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2022.112701openalex-snapshot
Nanodrug delivery systems and cancer stem cells: From delivery carriers to treatment
inferred← citeshttps://doi.org/10.1016/j.ejpb.2016.10.024openalex-snapshot
Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles
inferred← citeshttps://doi.org/10.1016/j.ejps.2023.106586openalex-snapshot
Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells
inferred← citeshttps://doi.org/10.1016/j.jconrel.2021.01.022openalex-snapshot
Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo
inferred← citeshttps://doi.org/10.1016/j.jddst.2019.05.024openalex-snapshot
Advanced drug delivery system with nanomaterials for personalised medicine to treat breast cancer
inferred← citeshttps://doi.org/10.1016/j.msec.2021.112024openalex-snapshot
Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways
inferred← citeshttps://doi.org/10.1016/j.msec.2021.112186openalex-snapshot
Multifunctional polymeric micellar nanomedicine in the diagnosis and treatment of cancer
inferred← citeshttps://doi.org/10.1016/j.nano.2019.102106openalex-snapshot
Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells
inferred← citeshttps://doi.org/10.1016/j.phytochem.2024.114072openalex-snapshot
10-Secocycloartane (=9,19-cyclo-9,10-secolanostane) triterpenoid saponins: Huangqiyenins M–X from Astragalus membranaceus (Fisch.) Bge
inferred← citeshttps://doi.org/10.1016/j.pmatsci.2023.101070openalex-snapshot
Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer
inferred← citeshttps://doi.org/10.1021/acsami.4c04135openalex-snapshot
3D Bioprinted Tumor-Stroma Models of Triple-Negative Breast Cancer Stem Cells for Preclinical Targeted Therapy Evaluation
inferred← citeshttps://doi.org/10.1021/acsanm.3c04714openalex-snapshot
Nanotechnology Meets Stem Cell Therapy for Treating Glioblastomas: A Review
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.1c00730openalex-snapshot
Phosphorylcholine-Installed Nanocarriers Target Pancreatic Cancer Cells through the Phospholipid Transfer Protein
inferred← citeshttps://doi.org/10.1038/s41598-022-15244-0openalex-snapshot
Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles
inferred← citeshttps://doi.org/10.1039/c6tb01329eopenalex-snapshot
Tailored mesoporous silica nanosystem with enhanced permeability of the blood–brain barrier to antagonize glioblastoma
inferred← citeshttps://doi.org/10.1080/09205063.2025.2515944openalex-snapshot
Hyaluronic acid-functionalized Axitinib nanomicelles for targeted drug delivery in breast cancer therapy
inferred← citeshttps://doi.org/10.1080/10717544.2018.1461276openalex-snapshot
AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells
inferred← citeshttps://doi.org/10.1080/21691401.2017.1366337openalex-snapshot
Nanocarrier based approaches for targeting breast cancer stem cells
inferred← citeshttps://doi.org/10.1101/2023.09.14.557721openalex-snapshot
The ALDH1A3 Reporter Construct: A Novel Mechanism of Identifying and Tracking the Breast Cancer Stem Cell Population
inferred← citeshttps://doi.org/10.1134/s0006297920090011openalex-snapshot
Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery
inferred← citeshttps://doi.org/10.1155/2018/4516454openalex-snapshot
Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells
inferred← citeshttps://doi.org/10.1186/s12645-020-00068-2openalex-snapshot
Nanotechnology approaches to addressing HER2-positive breast cancer
inferred← citeshttps://doi.org/10.1186/s12885-021-07831-7openalex-snapshot
Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s13287-023-03584-1openalex-snapshot
The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges
inferred← citeshttps://doi.org/10.1200/jco.18.01842openalex-snapshot
NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69–GeparSepto
inferred← citeshttps://doi.org/10.20517/cdr.2020.59openalex-snapshot
Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
inferred← citeshttps://doi.org/10.21203/rs.3.rs-686641/v1openalex-snapshot
Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
inferred← citeshttps://doi.org/10.21203/rs.3.rs-686641/v2openalex-snapshot
Selectively Targeting Breast Cancer Stem Cells By 8-Quinolinol and Niclosamide
inferred← citeshttps://doi.org/10.2147/ijn.s123437openalex-snapshot
Nanomedicine applications in the treatment of breast cancer: current state of the art
inferred← citeshttps://doi.org/10.2147/ijn.s368814openalex-snapshot
Antibody-Functionalized Nanoformulations for Targeted Therapy of Colorectal Cancer: A Systematic Review
inferred← citeshttps://doi.org/10.2147/sccaa.s72836openalex-snapshot
Stem cell technology in breast cancer: current status and potential applications
inferred← citeshttps://doi.org/10.2174/1381612826666200317132949openalex-snapshot
Eradicating the Roots: Advanced Therapeutic Approaches Targeting Breast Cancer Stem Cells
inferred← citeshttps://doi.org/10.2174/1381612826666200403131514openalex-snapshot
Targeted Delivery of Therapeutics to Urological Cancer Stem Cells
inferred← citeshttps://doi.org/10.2174/157489281703220610170559openalex-snapshot
Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer
inferred← citeshttps://doi.org/10.21873/anticanres.13514openalex-snapshot
Selective Wnt/β-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer
inferred← citeshttps://doi.org/10.2217/nnm-2016-0390openalex-snapshot
Unmet Needs in Developing Nanoparticles for Precision Medicine
inferred← citeshttps://doi.org/10.2217/nnm-2021-0013openalex-snapshot
Pluronic F127 Micelles Improve The Stability and Enhance The Anticancer Stem Cell Efficacy of Citral in Breast Cancer
inferred← citeshttps://doi.org/10.2217/nnm.15.200openalex-snapshot
Cancer Stem Cells and Personalized Cancer Nanomedicine
inferred← citeshttps://doi.org/10.29016/180629.1openalex-snapshot
Rational Design of a siRNA Delivery System: ALOX5 and Cancer Stem Cells as Therapeutic Targets
inferred← citeshttps://doi.org/10.32948/ajo.2024.10.30openalex-snapshot
Breast cancer stem cells origins and the memory stem cells: clinical significance of biomarkers and the active therapeutic approaches
inferred← citeshttps://doi.org/10.3389/fcell.2021.668851openalex-snapshot
Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells
inferred← citeshttps://doi.org/10.3389/fonc.2016.00145openalex-snapshot
Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance
inferred← citeshttps://doi.org/10.3389/fonc.2021.669250openalex-snapshot
Reporters of Cancer Stem Cells as a Tool for Drug Discovery
inferred← citeshttps://doi.org/10.3389/fphar.2016.00084openalex-snapshot
Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting
inferred← citeshttps://doi.org/10.3389/fphar.2016.00313openalex-snapshot
Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
inferred← citeshttps://doi.org/10.3390/cancers11081058openalex-snapshot
Pivotal Role of AKT2 during Dynamic Phenotypic Change of Breast Cancer Stem Cells
inferred← citeshttps://doi.org/10.3390/cancers17132100openalex-snapshot
Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities
inferred← citeshttps://doi.org/10.3390/cells12050720openalex-snapshot
Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer
inferred← citeshttps://doi.org/10.3390/ijms23052856openalex-snapshot
Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management
inferred← citeshttps://doi.org/10.3390/ijms231911760openalex-snapshot
Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
inferred← citeshttps://doi.org/10.3390/ijms26167935openalex-snapshot
Protein Marker-Dependent Drug Discovery Targeting Breast Cancer Stem Cells
inferred← citeshttps://doi.org/10.3390/nano10071424openalex-snapshot
Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy
inferred← citeshttps://doi.org/10.3390/pharmaceutics12020185openalex-snapshot
Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells
inferred← citeshttps://doi.org/10.3390/pharmaceutics12121146openalex-snapshot
Extracellular Vesicles as Drug Delivery Systems in Cancer
inferred← citeshttps://doi.org/10.3390/pharmaceutics14112432openalex-snapshot
Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.4252/wjsc.v13.i7.861openalex-snapshot
Reporter gene systems for the identification and characterization of cancer stem cells
inferred← citeshttps://doi.org/10.6084/m9.figshare.13719015openalex-snapshot
Additional file 1 of Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.13719018openalex-snapshot
Additional file 2 of Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.13719021openalex-snapshot
Additional file 3 of Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.13719024openalex-snapshot
Additional file 4 of Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.13719027openalex-snapshot
Additional file 5 of Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.70675/a2ec61f2z741bz401fz8cebz83e00b9aa005openalex-snapshot
Effets des neurotrophines dans l’enrichissement des cellules souches de cancer du sein et étude translationnelle dans le modèle canin
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.